Search Results - "Maida, Francesca"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Foodborne Botulism: Clinical Diagnosis and Medical Treatment by Lonati, Davide, Schicchi, Azzurra, Crevani, Marta, Buscaglia, Eleonora, Scaravaggi, Giulia, Maida, Francesca, Cirronis, Marco, Petrolini, Valeria Margherita, Locatelli, Carlo Alessandro

    Published in Toxins (07-08-2020)
    “…Botulinum neurotoxins (BoNTs) produced by species are the most potent identified natural toxins. Classically, the toxic neurological syndrome is characterized…”
    Get full text
    Journal Article
  2. 2

    Adverse Drug Reactions Related to Drug Administration in Hospitalized Patients by Gallelli, Luca, Siniscalchi, Antonio, Palleria, Caterina, Mumoli, Laura, Staltari, Orietta, Squillace, Aida, Maida, Francesca, Russo, Emilio, Gratteri, Santo, De Sarro, Giovambattista

    Published in Current drug safety (01-01-2017)
    “…Drug treatment may be related to the development of adverse drug reactions (ADRs). In this paper, we evaluated the ADRs in patients admitted to Catanzaro…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5

    Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes by Palleria, Caterina, Leporini, Christian, Maida, Francesca, Succurro, Elena, Sarro, Giovambattista De, Arturi, Franco, Russo, Emilio

    Published in Frontiers in neuroendocrinology (01-07-2016)
    “…Highlights • Diabetes is highly associated with cognitive impairment. • Lack of glycemic control (both hyper- or hypo-glycemia) increases the risk of cognitive…”
    Get full text
    Journal Article
  6. 6

    Urgent health concerns: Clinical issues associated with accidental ingestion of new metal-blade-containing sticks for heated tobacco products by Moro, Paola Angela, Maida, Francesca, Solimini, Renata, Spizzichino, Lorenzo, Pauwels, Charlotte G G M, Pieper, Elke, Havermans, Anne

    Published in Tobacco prevention & cessation (2024)
    “…Recently, a concerning pattern has emerged in clinical settings, drawing attention to the potential health risks associated with the accidental ingestion,…”
    Get full text
    Journal Article
  7. 7

    Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013-2016) analysis by Leporini, Christian, Piro, Rosanna, Ursini, Francesco, Maida, Francesca, Palleria, Caterina, Arturi, Franco, Pavia, Maria, De Sarro, Giovambattista, Russo, Emilio

    Published in Expert opinion on drug safety (01-12-2016)
    “…To compare patients' and physicians' perceptions regarding effectiveness and tolerability of non-insulin hypoglycemic drugs in a cohort of type 2 diabetic…”
    Get more information
    Journal Article
  8. 8

    Rare and very rare adverse effects of clozapine by De Fazio, Pasquale, Gaetano, Raffaele, Caroleo, Mariarita, Cerminara, Gregorio, Maida, Francesca, Bruno, Antonio, Muscatello, Maria Rosaria, Moreno, Maria Jose Jaén, Russo, Emilio, Segura-García, Cristina

    Published in Neuropsychiatric disease and treatment (01-01-2015)
    “…Clozapine (CLZ) is the drug of choice for the treatment of resistant schizophrenia; however, its suitable use is limited by the complex adverse effects'…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Recurrence of atrial fibrillation after switching from brand to generic atenolol by Gallelli, Luca, Maida, Francesca, Staltari, Orietta, Rende, Pierandrea, Russo, Emilio, Caroleo, Benedetto, De Sarro, Giovambattista

    “…Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left…”
    Get full text
    Journal Article
  11. 11